Federation des caisses Desjardins du Quebec’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,930
Closed -$4.83K 2625
2022
Q1
$4.83K Buy
2,930
+500
+21% +$892 ﹤0.01% 2204
2021
Q4
$5.81K Buy
2,430
+1,000
+70% +$4.07K ﹤0.01% 2166
2021
Q3
$7.81K Buy
1,430
+200
+16% +$1.24K ﹤0.01% 2121
2021
Q2
$9.15K Buy
1,230
+400
+48% +$2.83K ﹤0.01% 2075
2021
Q1
$6.72K Buy
830
+130
+19% +$1.42K ﹤0.01% 2110
2020
Q4
$6.37K Buy
+700
New +$5.74K ﹤0.01% 2012
2020
Q1
Sell
-500
Closed -$2.51K 2402
2019
Q4
$2.51K Buy
+500
New +$3.18K ﹤0.01% 2119

Other funds holding KLDO

Federation des caisses Desjardins du Quebec's KLDO Position: Q2 2022 in Review

Federation des caisses Desjardins du Quebec sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 2,930 shares — an estimated $4.83K sold.

Federation des caisses Desjardins du Quebec first reported a position in KLDO in Q4 2019 and held it in 7 quarters. The position peaked at $9.15K in Q2 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Federation des caisses Desjardins du Quebec reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 2,930 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $4.83K.
  • Federation des caisses Desjardins du Quebec first reported a position in Kaleido Biosciences, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Federation des caisses Desjardins du Quebec's Kaleido Biosciences, Inc. Common Stock position peaked at $9.15K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2022, filed 15 Aug 2024.